norfloxacin has been researched along with Obesity in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with norfloxacin and ampicillin for 2 weeks reduced the cecal bacterial DNA below the level of detection in ob/ob, diet-induced obese and insulin resistance (DIO) mice, and significantly improved fasting glycemia and oral glucose tolerance of the treated animals." | 2.44 | Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice. ( Blancher, F; Chou, CJ; Membrez, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, CJ | 2 |
| Membrez, M | 2 |
| Blancher, F | 2 |
| Jaquet, M | 1 |
| Bibiloni, R | 1 |
| Cani, PD | 1 |
| Burcelin, RG | 1 |
| Corthesy, I | 1 |
| Macé, K | 1 |
1 review available for norfloxacin and Obesity
| Article | Year |
|---|---|
Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Blood Glucose; Cecum; Diabetes Mellitus, Type 2; Glucose | 2008 |
1 other study available for norfloxacin and Obesity
| Article | Year |
|---|---|
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Bifidobacterium; Diabetes Mellitus, Type 2; | 2008 |